Healthcare Systems Bureau

What Does Full FDA Approval of Moderna COVID Vaccine Mean? Asks Association of American Physicians and Surgeons (AAPS)

Retrieved on: 
Wednesday, February 2, 2022
Public Readiness and Emergency Preparedness Act, CMS, Injury, RNA transfection, Physician, Association of American Physicians and Surgeons, FAA, OSHA, Federal Aviation Administration, Aircraft, COVID-19, GLOBE, Immunity, Association, Coercion, EUA, FDA, COVID19, Healthcare Systems Bureau, RNA, Emergency Use Authorization, Pharmaceutical industry, AAPS, Surgeon

There are now two approved shots, although BioNTechs Comirnaty is not yet available in the U.S., notes the Association of American Physicians and Surgeons (AAPS).

Key Points: 
  • There are now two approved shots, although BioNTechs Comirnaty is not yet available in the U.S., notes the Association of American Physicians and Surgeons (AAPS).
  • Manufacturers and providers of COVID-19 covered countermeasures have sweeping immunity from legal claims under the Public Readiness and Emergency Preparedness Act (PREP Act).
  • Attempts of vaccine resistors to assert this have been met with the reply that a threat of loss of livelihood does not constitute coercion, states AAPS.
  • The Association of American Physicians and Surgeons (AAPS) is a national organization representing physicians in all specialties since 1943.

28 State AGs Demand HHS Sec. Azar Enforce Laws on 340B Drug Pricing

Retrieved on: 
Tuesday, December 15, 2020
Managed care, General Health, Pharmaceutical, White House, Federal Government, State, Local, Infectious diseases, Public policy, Other Policy Issues, Medical Supplies, AIDS, Health, Public policy, Government, Health Resources and Services Administration, Drug pricing, 340B Drug Pricing Program, Health sciences, United States Department of Health and Human Services, United States federal executive departments, AIDS Healthcare Foundation, Alex Azar, Azar, Pharmaceutical industry, Healthcare Systems Bureau

AIDS Healthcare Foundation ( AHF ) praised 28 U.S. state attorneys general who have drawn a line in the sand to protect an essential part of the healthcare safety net: the 340B Drug Pricing Program against the limitless greed of the drug industry.

Key Points: 
  • AIDS Healthcare Foundation ( AHF ) praised 28 U.S. state attorneys general who have drawn a line in the sand to protect an essential part of the healthcare safety net: the 340B Drug Pricing Program against the limitless greed of the drug industry.
  • In their December 14 letter , the bipartisan group of elected attorneys general demand that U.S. Health and Human Services ( HHS ) Secretary Alex Azar take immediate steps to enforce the law to address drug companies unlawful refusal to provide critical drug discounts to covered entities such as community health centers under the 340B Drug Pricing Program.
  • View the full release here: https://www.businesswire.com/news/home/20201214005885/en/
    Letter to HHS Secretary Alex Azar from 28 state AGs demanding that he enforce the law on 340B drug pricing as required by section 340B of the U.S. Health Services Act.
  • AHF has repeatedly criticized these nine drug companies whose actions the AGs are calling unlawful.

Alliance of Community Health Centers Sues State to Preserve Benefits of the Federal 340B Drug Pricing Program

Retrieved on: 
Thursday, October 29, 2020
Health, Health Resources and Services Administration, Healthcare in the United States, 340B Drug Pricing Program, Drug pricing, Federally Qualified Health Center, Medicaid, Healthy Way LA, Healthcare Systems Bureau

SACRAMENTO, Calif., Oct. 29, 2020 /PRNewswire/ -- The Community Health Center Alliance for Patient Access (CHCAPA) has filed suit in federal court contesting the state's plan to 'carve out' the pharmacy benefit from Medicaid managed care, thus preventing community health centers from benefiting from the Federal 340B Drug Pricing Program.

Key Points: 
  • SACRAMENTO, Calif., Oct. 29, 2020 /PRNewswire/ -- The Community Health Center Alliance for Patient Access (CHCAPA) has filed suit in federal court contesting the state's plan to 'carve out' the pharmacy benefit from Medicaid managed care, thus preventing community health centers from benefiting from the Federal 340B Drug Pricing Program.
  • "The state's ill-conceived action threatens the ability of many community health centers to provide critical programs to uninsured and low-income families across the state," said Anthony White, President of the CHCAPA, a statewide organization of federally qualified health centers, serving 2.1 million patients.
  • "Medi-Cal patients depend on us for access to comprehensive primary and preventive health care," said Leslie Abasta-Cummings, CEO of Livingston Community Health, which operates six health centers in the Central Valley.
  • "Excluding our centers from the 340B Program will jeopardize patients' access to care, increase risk for health problems and raise costs," said Ronald E. Castle, CEO at Community Health Centers of the Central Coast, Inc., where he oversees 30 health centers and seven mobile dental and medical units.

Advocates Stand Up Against AstraZeneca to Save Drug Discount Program for Vulnerable Populations

Retrieved on: 
Tuesday, October 13, 2020
Infectious diseases, Public policy, Government, Healthcare reform, Philanthropy, AIDS, Pharmaceutical, Health, Public policy, Foundation, Other Policy Issues, Health, Health Resources and Services Administration, Drug pricing, Pharmaceuticals policy, 340B Drug Pricing Program, Prescription drug, American Society of Health-System Pharmacists, Lifeline, Healthcare Systems Bureau, Infectious diseases, Public policy, Government, Healthcare reform, Philanthropy, AIDS, Pharmaceutical, Health, Public policy, Foundation, Other Policy Issues, Health, Health Resources and Services Administration, Drug pricing, Pharmaceuticals policy, 340B Drug Pricing Program, Prescription drug, American Society of Health-System Pharmacists, Lifeline, Healthcare Systems Bureau

The federal 340B Drug Discount Program is a lifeline that allows safety net providers, including HIV/AIDS clinics receiving funding through the Ryan White program, to obtain prescription drugs at below-retail prices.

Key Points: 
  • The federal 340B Drug Discount Program is a lifeline that allows safety net providers, including HIV/AIDS clinics receiving funding through the Ryan White program, to obtain prescription drugs at below-retail prices.
  • The program was established with bipartisan support as part of the Veterans Health Care Act of 1992.
  • The program also benefits qualified 340B covered entities such as non-profit rural health facilities, community clinics and childrens hospitals that serve vulnerable populations.
  • AstraZeneca has launched an assault on a federal drug discount program essential to the safety net of our nations health care, stated John Hassell, AHFs national director of advocacy.

AHF Warns Pharma Its Attacks on 340B Drug Program Will Harm Patients

Retrieved on: 
Tuesday, September 8, 2020
AIDS, Other Health, Diabetes, Health, Healthcare reform, Public policy, Pharmaceutical, Infectious diseases, Hospitals, Congressional News, Views, Public policy, Government, Health Resources and Services Administration, Drug pricing, 340B Drug Pricing Program, AIDS Healthcare Foundation, Health, Articles, AHF, Pharmaceutical industry, Rebate, Healthcare Systems Bureau

AIDS Healthcare Foundation ( AHF ) condemns the latest series of attempts by drug manufacturers to undermine an essential part of the healthcare safety net, the 340B Drug Pricing Program .

Key Points: 
  • AIDS Healthcare Foundation ( AHF ) condemns the latest series of attempts by drug manufacturers to undermine an essential part of the healthcare safety net, the 340B Drug Pricing Program .
  • Make no mistake, the 340B Program is under attack, said Tracy Jones, AHF senior manager and executive director of the AIDS Task Force of Greater Cleveland, an AHF affiliate.
  • Finally, drug companies are trying to convert the program from a discount program into a rebate program.
  • Its no secret that drug companies dont like the 340B program, because providing discounts to safety net providers eats into their profits.

Omnicell to Acquire Pharmaceutical Strategy Group’s Leading 340B Software-Enabled Service Business

Retrieved on: 
Wednesday, August 12, 2020
Health, Data management, Pharmaceutical, Technology, Software, Health Resources and Services Administration, Drug pricing, 340B Drug Pricing Program, Business, Economy, Healthcare Systems Bureau, Pharmaceutical Strategies Group (PSG), Omnicell

The federal 340B Drug Pricing Program has provided financial assistance to hospitals serving vulnerable communities for more than 25 years.

Key Points: 
  • The federal 340B Drug Pricing Program has provided financial assistance to hospitals serving vulnerable communities for more than 25 years.
  • The importance of the 340B program continues to grow as covered entities seek solutions to help manage rising healthcare costs and uncompensated care.
  • Adds High-Growth, Immediately Accretive, Recurring Revenue Business: 340B Link is a high growth software-enabled services business with a recurring revenue business model, aligned with customer success.
  • Complementary to Omnicell One: 340B Links capabilities are complementary to Omnicell One, Omnicells recently-announced, technology-enabled service which focuses on pharmacy supply chain optimization and diversion management.

HHS to Award 1,273 Community Health Centers Across the USA With Grants, to Improve Healthcare

Retrieved on: 
Wednesday, October 2, 2019
Health, Health Resources and Services Administration, Office of Rural Health Policy, Healthcare Systems Bureau

The Fund which has been provided by the Health Resources and Services Administration (HRSA) aims at delivering better value from the care they receive and, ultimately, better health.

Key Points: 
  • The Fund which has been provided by the Health Resources and Services Administration (HRSA) aims at delivering better value from the care they receive and, ultimately, better health.
  • To make proper fund distribution to health centers across the country possible HRSA uses theElectronic Handbooks(EHBs) System.
  • "Every year it helps tens of millions of Americans receive quality, affordable health care, and other services.
  • In 2018 alone, these health centers provided over 2.4 million HIV tests to more than 2 million patients.

ABT AWARDED POSITION ON $250M HHS CONTRACT ADDRESSING ISSUES RANGING FROM SUBSTANCE USE DISORDERS AND HIV/AIDS TO MATERNAL AND CHILD HEALTH

Retrieved on: 
Wednesday, August 28, 2019
Health, Articles, Health Resources and Services Administration, HIV/AIDS Bureau, Health care, Reproductive health, Elizabeth Duke, Healthcare Systems Bureau

An Abt Associates-led team has been awarded a position on a $250 million, five-year indefinite delivery/indefinite quantity (IDIQ) contract that addresses a variety of health challenges.

Key Points: 
  • An Abt Associates-led team has been awarded a position on a $250 million, five-year indefinite delivery/indefinite quantity (IDIQ) contract that addresses a variety of health challenges.
  • This gives the Abt team the right to bid on task orders covering issues ranging from substance use disorders and HIV/AIDS to maternal and child healthcare.
  • The contract calls for technical assistance for the HIV/AIDS Bureau, Maternal Child Health Bureau and the Bureaus of Primary Health Care and Health Workforce, which are part of the Department of Health and Human Services Health Resources and Services Administration (HRSA).
  • We have extensive experience working with HRSA and substantive expertise in improving health systems and health care delivery, including on-the-ground experience in clinical care said Christopher Spera, Ph.D., Abt vice president of health and environment.

California Hospital Association Supports New Federal Legislation to Protect 340B Drug Discount Program

Retrieved on: 
Tuesday, June 12, 2018
Health, Health Resources and Services Administration, Pharmaceuticals policy, Pharmacy, 340B Drug Pricing Program, Prescription drug, Healthcare Systems Bureau

SACRAMENTO, June 12, 2018 /PRNewswire-USNewswire/ --The California Hospital Association (CHA) has announced its support for new federal legislation that would protect and enhance the long-standing 340B drug discount program, which allows safety-net hospitals, community clinics and other providers that serve low-income and vulnerable patients to purchase outpatient medications at a discount from drug manufacturers.

Key Points: 
  • SACRAMENTO, June 12, 2018 /PRNewswire-USNewswire/ --The California Hospital Association (CHA) has announced its support for new federal legislation that would protect and enhance the long-standing 340B drug discount program, which allows safety-net hospitals, community clinics and other providers that serve low-income and vulnerable patients to purchase outpatient medications at a discount from drug manufacturers.
  • "The savings gleaned from the 340B program allow hospitals to make critical, cost-effective investments to improve the health and well-being of their communities," said CHA President & CEO Carmela Coyle.
  • "This legislation will improve the integrity and transparency of the program, while enabling hospitals to continue to be exemplary stewards of these vital resources."
  • With bipartisan support, Congress created the 340B drug discount program in 1992 to offer financial relief from high prescription drug costs to health care providers who care for low-income and indigent populations.